News
7h
InvestorsHub on MSNTempus AI shares climb after FDA approval of heart monitoring softwareTempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) ...
With the help of artificial intelligence (AI), an inexpensive test found in many doctors' offices may soon be used to screen ...
With the help of artificial intelligence (AI), an inexpensive test found in many doctors' offices may soon be used to screen ...
Doctors have long called hypertrophic cardiomyopathy (HCM) “the great masquerader. ” It hides in plain sight, often mistaken ...
This marks the second FDA-cleared ECG-AI device in Tempus’ cardiovascular product suite, following its previously cleared Tempus ECG-AF solution. The new software analyzes resting, non-ambulatory ...
The healthcare industry is experiencing a significant shift, driven largely by the rise of artificial intelligence (AI) and ...
The era of predictive modeling enhanced with machine learning and artificial intelligence (AI) to aid clinical ...
The findings, published in the European Heart Journal, point out that the AI model was highly accurate, with 85% sensitivity ...
Kevin Choi uses AI to detect critical diseases early through retinal scans. He said AI helps in screening, but it won't ...
Testing the Scanner According to the Independent, the AI scanner was tested on 26 heart-failure patients from five NHS trusts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results